Traws Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,733 | $57 | $56 | $57 |
Gross Profit | 2,733 | 56 | 54 | 55 |
EBITDA | -914 | 21,491 | -29,920 | -8,473 |
EBIT | -915 | 21,490 | -29,922 | -8,475 |
Net Income | -915 | 15,083 | 81,927 | -8,475 |
Net Change In Cash | 2,733 | 57 | 56 | 57 |
Free Cash Flow | -11,410,563 | -5,437 | -4,040 | -11,476 |
Cash | 13,081 | 15,937 | 21,338 | 5,410 |
Basic Shares | 5,820 | 7,215 | 3,650 | 961 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $226 | $226 | $226 | $226 |
Gross Profit | 214 | 210 | 212 | 212 |
EBITDA | -166,511 | -18,932 | -18,950 | -16,148 |
EBIT | -166,523 | -18,948 | -18,964 | -16,162 |
Net Income | -54,674 | -18,948 | -18,964 | -16,163 |
Net Change In Cash | 226 | 226 | 226 | 226 |
Free Cash Flow | -29,792 | -17,946 | -16,294 | -19,487 |
Cash | 21,338 | 20,821 | 38,757 | 55,070 |
Basic Shares | 1,552 | 839 | 836 | 673 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.16 |
2025-03-31 | $22.44 |
2024-12-31 | $26.60 |
2024-09-30 | -$8.81 |
